window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : June 22, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us
Veeva Systems Leaderboard Advert
DP Magazine HomeDebbie2026-06-22T10:45:15+01:00
Top News
Jun 22: Pierre Fabre wins EU approval for first-line BRAFTOVI regimen in BRAF-mutant colorectal cancer
Jun 22: African health leaders launch Imara framework to strengthen sickle cell disease care across Africa
Jun 22: Houdini Bio develops DNA design platform targeting gene therapy silencing
Jun 22: Singapore researchers develop nanosensor for rapid gut biomarker detection
Jun 22: Lubrizol excipient recognised at CPhI China Pharma Excipients Awards
  • Advanced Therapies,Drug Discovery & Development

    Spot Biosystems reports early clinical evidence for non-viral dystrophin delivery in Duchenne muscular dystrophy

    By Liza Laws|Last Updated: 18 June 2026|
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    Pierre Fabre wins EU approval for first-line BRAFTOVI regimen in BRAF-mutant colorectal cancer

  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    African health leaders launch Imara framework to strengthen sickle cell disease care across Africa

top headlines

  • Advanced Therapies

    Houdini Bio develops DNA design platform targeting gene therapy silencing

    Houdini Bio has launched a machine learning-guided DNA sequence design [...]

    June 19, 2026
  • Medical devices

    Singapore researchers develop nanosensor for rapid gut biomarker detection

    Researchers in Singapore have developed a fluorescent nanosensor capable of [...]

    June 19, 2026
related posts
  • Lubrizol excipient recognised at CPhI China Pharma Excipients Awards
    By Liza Laws|Categories: Drug Delivery & Formulation|
  • AI adoption grows in life science labs but data integration remains a barrier, survey finds
    By Liza Laws|Categories: Digital & Data|
  • Olorofim meets primary endpoint in phase 3 OASIS aspergillosis study
    By Liza Laws|Categories: Biotech & Pharma Business, Clinical & Regulatory, Pharmaceuticals and therapeutics|
related posts
  • Spot Biosystems reports early clinical evidence for non-viral dystrophin delivery in Duchenne muscular dystrophy
    By Liza Laws|Categories: Advanced Therapies, Drug Discovery & Development|
  • Neurizon strengthens manufacturing base with Elanco supply deal for ALS asset
    By Liza Laws|Categories: Biotech & Pharma Business, Manufacturing & Supply Chain|
  • OrganaBio expands European access to perinatal and blood-derived research materials through Bio-Connect partnership
    By Liza Laws|Categories: Advanced Therapies, Biotech & Pharma Business|

Movers & Shakers

  • Allucent adds strategy leaders to expand therapeutic expertise
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Drug Discovery & Development, Therapeutic Areas
  • Genmab appoints Margarida Duarte as general manager for Europe and emerging markets
    Categories: Biotech & Pharma Business, Pharmaceuticals and therapeutics
  • Opella appoints former Reckitt executive Gonzalo Balcazar to lead Europe and Latin America
    Categories: Biotech & Pharma Business, Pharmaceuticals and therapeutics
  • Orano Med appoints Frederic Desdouits as CEO to advance targeted alpha therapy pipeline
    Categories: Biotech & Pharma Business, Drug Discovery & Development, Pharmaceuticals and therapeutics, Therapeutic Areas
  • Aravax adds allergy specialists to board as peanut therapy advances
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Therapeutic Areas

sponsored content

Biotech & Pharma Business,Digital & Data

Turning AI Skeptics into AI Advocates Through High-Integrity Data

With 89% of AI pilots failing to scale, biopharmas can [...]

continue readingcontinue reading
Biotech & Pharma Business,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics

SGD Pharma highlights GLP-1 demand, supply chain pressure and sustainability focus at DCAT Week

Interview with Carol Grassi Mircich, chief commercial marketing and innovation [...]

continue readingcontinue reading
Clinical & Regulatory,Therapeutic Areas

Rare Disease Day 2026: Cereno Scientific advances disease-modifying therapies in PAH

As Rare Disease Day 2026 shines a spotlight on patients [...]

continue readingcontinue reading
Therapeutic Areas

Rare Disease Day 2026: Er-Kim pushes to close access gap in underserved markets

As Rare Disease Day 2026 highlights the challenges faced by [...]

continue readingcontinue reading

Other news

  • Drug Delivery & Formulation

    Lubrizol excipient recognised at CPhI China Pharma Excipients Awards

    Lubrizol’s Apisolex polymer has received a Silver award at the [...]

    read more
  • Digital & Data

    AI adoption grows in life science labs but data integration remains a barrier, survey finds

    More than 60% of life science laboratories are exploring or [...]

    read more
  • Biotech & Pharma Business,Clinical & Regulatory,Pharmaceuticals and therapeutics

    Olorofim meets primary endpoint in phase 3 OASIS aspergillosis study

    F2G and Shionogi have reported that oral olorofim met the [...]

    read more
  • Biotech & Pharma Business,Manufacturing & Supply Chain

    Neurizon strengthens manufacturing base with Elanco supply deal for ALS asset

      Neurizon has entered a long-term supply agreement with Elanco [...]

    read more
  • Advanced Therapies,Biotech & Pharma Business

    OrganaBio expands European access to perinatal and blood-derived research materials through Bio-Connect partnership

    OrganaBio has expanded access to its perinatal and peripheral blood-derived [...]

    read more
  • Biotech & Pharma Business,Manufacturing & Supply Chain

    Single use support launches next-generation controlled-rate blast freezer

    Single Use Support has launched its RoSS.BLST controlled-rate blast freezer, [...]

    read more
Mail Icon

news via inbox

Sign up for our newsletter and get the latest news right in your inbox

SUBSCRIBE

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Bio-Europe unveils renewed vision as global biopharma strategy forum
    Categories: Biotech & Pharma Business, Opinion & Events
  • Ananda Pharma Phase 1 study of MRX1 shows safety and supports Phase 2 progression
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics
  • Scribe Therapeutics secures $25M CIRM backing to advance CRISPR cardiometabolic therapies
    Categories: Advanced Therapies, Biotech & Pharma Business, Clinical & Regulatory, Genomics and sequencing, Pharmaceuticals and therapeutics, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top